Terumo Co. (OTCMKTS:TRUMY) Short Interest Down 44.5% in May

Terumo Co. (OTCMKTS:TRUMY - Get Free Report) saw a significant decline in short interest in May. As of May 15th, there was short interest totalling 30,200 shares, a decline of 44.5% from the April 30th total of 54,400 shares. Based on an average trading volume of 180,600 shares, the short-interest ratio is presently 0.2 days. Approximately 0.0% of the shares of the stock are short sold.

Terumo Trading Up 0.5%

Shares of OTCMKTS:TRUMY traded up $0.10 during midday trading on Tuesday, hitting $18.45. 227,934 shares of the stock traded hands, compared to its average volume of 167,684. The stock has a market capitalization of $27.32 billion, a PE ratio of 35.48 and a beta of 0.88. The business's 50 day moving average is $18.87 and its two-hundred day moving average is $18.98. The company has a quick ratio of 1.70, a current ratio of 2.94 and a debt-to-equity ratio of 0.12. Terumo has a one year low of $14.06 and a one year high of $21.22.

Terumo (OTCMKTS:TRUMY - Get Free Report) last announced its quarterly earnings results on Wednesday, May 14th. The company reported $0.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.15 by ($0.07). The company had revenue of $1.79 billion for the quarter, compared to the consensus estimate of $1.79 billion.

Terumo Company Profile

Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. The company operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company.